Summa Equity to sell HyTest to Mindray
Summa Equity has agreed to sell HyTest to Mindray for 545 million euros.
17 May 2021•3 mins read
Summa Equity has agreed to sell HyTest to Mindray for 545 million euros.
New Mountain’s Grant Thornton Advisors closes $5bn take-private of CBIZ
57 minutes ago · 2 mins read
Interlock Equity seals $525m sale of Lovelytics to CDW
1 hour ago · 2 mins read
Accel-KKR’s VisiQuate buys Finvi’s Artiva HCx revenue cycle business
1 hour ago · 2 mins read
May River Capital agrees to $675m sale of Parameter Technologies to Acuity
1 hour ago · 1 min read
Onyx Partners strikes two-phase deal for Florida retailer Kane’s Furniture
1 hour ago · 1 min read
Kester-backed Evestia Clinical acquires Belgian medical writing firm Emtex in third add-on
2 hours ago · 1 min read
Weatherford Capital invests in Arnold Palmer Junior Golf Tour alongside Bolt Ventures
2 hours ago · 2 mins read
